Belgium

Together with over 400 external stakeholders from across 50 countries, PATH has crafted a new institutional strategy that responds to the current crises we face as a global community, to the needs and priorities of our local partners, and to the resounding calls for the continued transformation of our sector. To bring our new strategy to life for our external partners, we’ve developed a strategy brochure. The brochure explains why PATH exists (our mission), what we will do (our priorities) and, perhaps most importantly, how we will do it (our change strategies).

The European Union (EU) is a critical investor in the global effort to develop innovative solutions to the world's biggest health challenges. This two-page brief covers the EU's history of supporting global health research and innovation, and lays out some next steps to build on this leadership and support a strong EU-Africa partnership.

As decisions are being made about the future of partnerships under Horizon Europe, PATH and other Product Development Partnership (PDP) organizations call on the EU to once again include an ambitious partnership exclusively dedicated to funding research for the prevention and treatment of poverty-related and neglected diseases. In this position paper, PATH and partners specifically encourage enhanced partnership opportunities to bolster collaboration and leverage funding from partners, including PDPs and the private and philanthropic sectors, a more flexible portfolio approach to funding, and an ambitious doubling of the program to 1.36 billion Euros from the European Commission.

PATH is the secretariat of The Reproductive Health Supplies Coalition, a global partnership of public, private, and non-governmental organizations dedicated to ensuring that all people in low- and middle-income countries can access and use affordable, high-quality supplies to ensure their better reproductive health.